Poirier, J T
Gardner, E E
Connis, N
Moreira, A L
de Stanchina, E
Hann, C L
Rudin, C M
Article History
Received: 3 September 2013
Revised: 16 January 2014
Accepted: 27 January 2015
First Online: 9 March 2015
Competing interests
: CMR has been a paid consultant regarding cancer drug development for AbbVie, Aveo, Celgene, GlaxoSmithKline and Merck. The remaining authors declare no conflict of interest.